Delivery Order SPE2DX22D0090-SPE2D826FAB9F
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $53,510.73 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed price delivery order, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,908.71 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price, competitively awarded delivery order was issued on October 13, 2025, with an ultimate completion date of October 14, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a child contract under...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $11,248.75 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitive award, issued on November 9, 2025, with an ultimate completion date of November 10, 2025, utilizes firm fixed pricing with no set-aside designation. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $6,393.33 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. Awarded on October 3, 2025, with a completion date of October 6, 2025, this firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,683.97 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on June 30, 2025, with an ultimate completion date of July 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $28,510.40 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This non-competitive delivery order, issued on September 29, 2025, with a completion date of September 30, 2025, is structured as a firm fixed price contract. The award is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. This firm fixed price delivery order, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-set-aside, competitively awarded contract. The award is a child contract under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $20,576.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed price, non-set-aside delivery order was executed on November 5, 2025, with an ultimate completion date of November 6, 2025. The award represents a child contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $68,633.28 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was competitively procured and will be performed at the contractor's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $34,875.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on October 20, 2025, with an ultimate completion date of October 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract...
- SPE2DX22D0090Indefinite Delivery Contract
- SPE2DX22D0090-SPE2D826FAB9FDelivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,551.95 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, with performance occurring at the company's Conshohocken facility. AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying pharmaceutical products and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. This delivery order is part of AmerisourceBergen's comprehensive engagement with the Defense Logistics Agency, which includes a significant $999.999 billion indefinite delivery contract (SPE2DX) running through December 2026 that enables the company to supply pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities globally to support military healthcare programs. The company's federal contract portfolio demonstrates consistent capability to fulfill competitive medical supply requirements through firm fixed-price delivery orders, ranging from nominal values to substantial orders, and supports critical customers including the Defense Health Agency and U.S. Coast Guard. The DLA Troop Support is currently planning next-generation Pharmaceutical Prime Vendor Global Program contracts anticipated to involve multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 11/10/25 |